Biotech start-up Vaccitech files for US IPO
Vaccitech owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca
Author
Private genomics industry may be called upon to speed up strategic genome surveillance initiatives
Clevergene, a tech company, offers genomics services for contract research and genetic diagnostics. In an interview, Tony Jose,…
COVID-19 has created a level playing field for innovators to get their products to market
Ashutosh Mayank and Prajakt Raut, Managing Partners at Supply Chain Labs, Lumis Partners share their insights on new opportunities…
Is Women’s Health gaining momentum?
In Express Pharma’s Women’s Day Special issue, some industry observers and pharma stakeholders share insights on opportunities,…
Regulatory agencies have provided various leverages to adopt digital technologies in business…
Souvik Chatterjee, Practice Head, Pharma at Tata Elxsi talks about how the COVID-19 pandemic has accelerated tech-transformations…
Quality, turn-around-times and cost are major pain points in life sciences, CRO and pharma…
Vinay Raj, VP, Reverie Language Technologies explains the need for transparency and reliability in the translation life cycle of…
Cyber resilience: A high priority
The COVID-19 pandemic has accelerated digitalisation and automation in the pharma sector. But, as the risk landscape of the pharma…
COVID-19 has accelerated innovation and experimentation in therapy development and clinical trials
Sunil Punjabi, Country Speaker & Head of Research Solutions Commercial, Merck India outlines how the COVID-19 pandemic is…
Avantor is playing a pivotal role in partnering with organizations working on COVID-19 therapies
Devashish Ohri, Executive VP - India, Middle East & Africa (IMEA) elaborates on Avantor’s contributions to tackle the COVID-19…
We need companies to apply access approaches more systematically, consistently and at a larger scale…
Claudia Martinez, Lead for the Access to Medicine Index shares more insights from this year's report and recommends steps to…
